Clean Bulk Protocol Framework Caloric Approach Training days: Maintenance plus 200-300 calories, focused around workout window Rest days: Maintenance or slight deficit (100-200 calories below) Weekly average: Approximately maintenance to slight surplus Macronutrient Priorities Protein: 0.9-1.1 grams per pound of body weight daily (non-negotiable minimum) Carbohydrates: Concentrated around training for performance and recovery Fats: Moderate intake (0.3-0.4 grams per pound) for hormone support Expected Outcomes (6-12 months) Scale weight: May decrease, maintain, or slowly increase depending on starting point Body fat percentage: Decrease of 3-8% Lean mass: Maintenance or gradual increase (0.25-0.5 pounds per week average) For individuals starting from higher body fat levels (above 18% for males or 25% for females), the initial phase with Retatrutide will likely emphasize fat loss while preserving existing muscle
Research evaluates KPV through cytokine panels, NF kappa B linked signalling markers, and epithelial barrier associated readouts in skin and gastrointestinal models
& Zhou, H
Its primary evidence base is in antioxidant support, immune function, and liver health
Clinical Trial Results and Effectiveness Datopotamab deruxtecan-dlnk (Datroway) was approved by the FDA based on strong results from clinical trials in patients with advanced breast and lung cancers that had stopped responding to other treatments
"Intelligent testing Page 220 and 221: Ikegawa S, Hasegawa M, Okihara R, S Page 222 and 223: Page 224 and 225: Iversen A, Kuhn I, Franklin A, and Page 226 and 227: Jang Y-C, Lee C, Yoon O-S, and Kim Page 228 and 229: Chemosphere 2003, 50(3):437-443
